Literature DB >> 25911271

Success and Complications of Salpingectomy at the Time of Vaginal Hysterectomy.

Magali Robert1, David Cenaiko2, Jasmine Sepandj3, Stanislaw Iwanicki2.   

Abstract

STUDY
OBJECTIVES: To document the success rates and complications of salpingectomy performed at the time of vaginal hysterectomy to possibly reduce ovarian cancer rates.
DESIGN: Retrospective cohort study (Canadian Task Force Classification II-2).
SETTING: Community-based hospital with university affiliation in Calgary, Canada. INTERVENTION: All women undergoing hysterectomy for benign conditions were offered preferentially a vaginal approach with prophylactic salpingectomy.
MEASUREMENTS AND MAIN RESULTS: During the study period (October 2011 to January 2014), a total of 425 vaginal hysterectomies were performed. The overall success rate of salpingectomy was 88%. Pelvic adhesions significantly predicted the ability to perform salpingectomies (odds ratio, 6.3; 95% confidence interval, 2.8-14.3; p < .001). Age also was predictive of outcomes (p = .007), with increasing age predicting decrease success. The overall postoperative complication rate was 15%, with 3.8% possibly attributable to salpingectomy (i.e., intrapelvic complications). No associated factors were found on regression analysis.
CONCLUSION: Salpingectomy at the time of vaginal hysterectomy is a feasible procedure. Complication rates are low. Only pelvic adhesions are associated with failure to complete a salpingectomy.
Copyright © 2015 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Surgical outcome; Vaginal salpingectomy

Mesh:

Year:  2015        PMID: 25911271     DOI: 10.1016/j.jmig.2015.04.012

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  8 in total

1.  Feasibility of prophylactic salpingectomy during vaginal hysterectomy.

Authors:  Danielle D Antosh; Rachel High; Heidi W Brown; Sallie S Oliphant; Husam Abed; Nisha Philip; Cara L Grimes
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 8.661

2.  Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.

Authors:  Gery Lamblin; Capucine Meysonnier; Stéphanie Moret; Béatrice Nadaud; Georges Mellier; Gautier Chene
Journal:  Int Urogynecol J       Date:  2017-07-13       Impact factor: 2.894

3.  Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Authors:  Emily A Slopnick; David D Sheyn; Graham C Chapman; Sangeeta T Mahajan; Sharif El-Nashar; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-05-21       Impact factor: 2.894

4.  Adnexal surgery at the time of hysterectomy in women 65 years and older undergoing hysterectomy for prolapse: do practice trends differ by route of surgery?

Authors:  Kristie A Greene; Allison M Wyman; Nupur Tamhane; Jean Paul Tanner; Renee M Bassaly; Jason L Salemi
Journal:  Int Urogynecol J       Date:  2021-03-03       Impact factor: 2.894

5.  Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.

Authors:  Laura A M van Lieshout; Miranda P Steenbeek; Joanne A De Hullu; M Caroline Vos; Saskia Houterman; Jack Wilkinson; Jurgen Mj Piek
Journal:  Cochrane Database Syst Rev       Date:  2019-08-28

6.  Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey.

Authors:  Miranda P Steenbeek; Laura A M van Lieshout; Johanna W M Aarts; Jurgen M J Piek; Sjors F P J Coppus; Leon F A G Massuger; Rosella P M G Hermens; Joanne A de Hullu
Journal:  J Gynecol Oncol       Date:  2018-04-30       Impact factor: 4.401

7.  Changes in Hysterectomy Route and Adnexal Removal for Benign Disease in Australia 2001-2015: A National Population-Based Study.

Authors:  Natalie De Cure; Stephen J Robson
Journal:  Minim Invasive Surg       Date:  2018-05-31

8.  Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures.

Authors:  Gautier Chene; Sarah Urvoas; Stéphanie Moret; Béatrice Nadaud; Annie Buenerd; Philippe Chabert; Georges Mellier; Gery Lamblin
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.